-
Study aim
-
Evaluation of the effect of greater occipital nerve block in the treatment of medication overuse headache
-
Design
-
The current study is an open label, parallel, randomized, controlled clinical trial. Participants who fulfilling the inclusion criteria will be randomized in 1:1 ratio to either group A (n=27) or B (n=27) by permuted blocked randomization.
-
Settings and conduct
-
We consecutively evaluated patients with a suspect of medication overuse headache in the Imam Moosa Sadr clinic, Isfahan University of Medical Sciences, Isfahan, Iran. In both group, patients underwent detoxification processes without any analgesics during 3 months. The detoxification is a therapeutic process in which the effects of analgesics in causing medication overuse headache are eliminated. Greater occipital nerve blocks are performed in patients in the intervention group, and the control group will simply undergo the detoxification process without the nerve block.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Adult patients (aged >18 years), having confirmed diagnosis of medication overuse headache (MOH), previous diagnosis of a primary headache.
Exclusion criteria: Psychiatric disorders (e.g. severe depression or schizophrenia), physical disorders (e.g. malignancy, concomitant heart disease), pregnant or lactating.
-
Intervention groups
-
In both group, patients underwent detoxification processes without any acute migraine medication or analgesics. Greater occipital nerve blocks are performed in patients in the intervention group, and the control group will simply undergo the detoxification process without the nerve block.
-
Main outcome variables
-
Characteristics of headache attacks including headache severity, frequency and duration.